A multicenter Chinese study reported an AI-based MRI nomogram that uses clinical features plus AI-derived “tumor habitat” signatures to predict high-risk hepatocellular carcinoma prior to surgery. The model aims to identify patients more likely to face recurrence and to stratify risk in a way that could improve surgical planning. The work builds on the broader push to extract lesion subregions and imaging-based microenvironment cues, typically framed as radiomics or habitat features. By combining clinical variables with model-derived predictors, the study suggests more than one signal source contributes to risk stratification. For clinicians and developers, the main implication is workflow compatibility: the inputs are available before surgery, and the output is intended to guide decisions about prognosis and follow-up intensity. However, the sector will still require external validation and prospective evaluation to determine whether the tool changes treatment selection in practice rather than just improving retrospective metrics.